Amedeo Smart

Free Medical Literature Service


 

Amedeo

Hepatitis C

  Free Subscription

Articles published in
J Med Virol
    November 2021
  1. BOLINA-SANTOS E, Chaves DG, da Silva-Malta MCF, Carmo RA, et al
    HCV infection in hemophilia A patients is associated with altered cytokines and chemokines profile and might modulate the levels of FVIII inhibitor.
    J Med Virol. 2021 Nov 5. doi: 10.1002/jmv.27432.
    >> Share

    October 2021
  2. JI Q, Chu X, Zhou Y, Liu X, et al
    Safety and efficacy of grazoprevir/elbasvir in the treatment of acute hepatitis C in hemodialysis patients.
    J Med Virol. 2021 Oct 2. doi: 10.1002/jmv.27374.
    >> Share

    September 2021
  3. KAZMI SK, Khan FMA, Natoli V, Hunain R, et al
    Viral hepatitis amidst COVID-19 in Africa: Implications and Recommendations.
    J Med Virol. 2021 Sep 10. doi: 10.1002/jmv.27330.
    >> Share

  4. NICOLINI LA, Menzaghi B, Molteni C, Vichi F, et al
    Comments on "Real-world re-treatment outcomes of direct-acting antiviral therapy failure in patients with chronic hepatitis C".
    J Med Virol. 2021 Sep 9. doi: 10.1002/jmv.27329.
    >> Share

    August 2021
  5. ZHOU R, Liu L, Wang Y
    Viral Proteins Recognized by Different TLRs.
    J Med Virol. 2021 Aug 10. doi: 10.1002/jmv.27265.
    >> Share

    July 2021
  6. WEI MT, Le MH, Landis C, Trinh H, et al
    Evaluation of ethnic influence in the application of a hepatocellular carcinoma predictive model for chronic hepatitis C.
    J Med Virol. 2021 Jul 5. doi: 10.1002/jmv.27168.
    >> Share

    June 2021
  7. LEUMI S, El Kassas M, Zhong J
    Hepatitis C virus-genotype 4: a poorly characterized endemic genotype.
    J Med Virol. 2021 Jun 29. doi: 10.1002/jmv.27165.
    >> Share

  8. TADA T, Kurosaki M, Nakamura S, Hasebe C, et al
    Real-world clinical outcomes of sofosbuvir and velpatasvir treatment in HCV genotype 1- and 2-infected patients with decompensated cirrhosis: A nationwide multicenter study by the Japanese Red Cross Liver Study Group.
    J Med Virol. 2021 Jun 25. doi: 10.1002/jmv.27157.
    >> Share

    April 2021
  9. BULFONI M, Pravisani R, Dalla E, Cesselli D, et al
    miRNA expression profiles in liver grafts of HCV and HIV/HCV infected recipients, six months after liver transplantation.
    J Med Virol. 2021 Apr 5. doi: 10.1002/jmv.26999.
    >> Share

    March 2021
  10. ELHENCE A, Singh A, Anand A, Kumar R, et al
    Real-World Re-Treatment Outcomes of Direct-Acting Antiviral Therapy Failure in Patients with Chronic Hepatitis C.
    J Med Virol. 2021 Mar 30. doi: 10.1002/jmv.26971.
    >> Share

  11. FEDORCHENKO SV, Martynovych T, Klimenko Z, Solianyk I, et al
    Effectiveness of retreatment with ombitasvir/paritaprevir/ritonavir, dasabuvir + sofosbuvir + ribavirin in patients with chronic hepatitis C, subtype 1b and cirrhosis, who failed previous with first- and second-generation NS5A inhibitors.
    J Med Virol. 2021 Mar 11. doi: 10.1002/jmv.26935.
    >> Share

    December 2020
  12. MIRANDA NTGP, de Souza RL, Monteiro JC, Costa IB, et al
    Seroprevalence of HBV and HCV in female sex workers from four cities in the state of Para, northern Brazil.
    J Med Virol. 2020 Dec 25. doi: 10.1002/jmv.26759.
    >> Share

    November 2020
  13. CHUA JV, Ntem-Mensah A, Abutaleb A, Husson J, et al
    Short-duration treatment with the novel non-nucleoside inhibitor CDI-31244 plus sofosbuvir/velpatasvir for chronic hepatitis C: an open-label study.
    J Med Virol. 2020 Nov 5. doi: 10.1002/jmv.26652.
    >> Share

    September 2020
  14. HIGUCHI M, Tamaki N, Kurosaki M, Inada K, et al
    Changes of liver stiffness measured by magnetic resonance elastography during direct-acting antivirals treatment in patients with chronic Hepatitis C.
    J Med Virol. 2020 Sep 5. doi: 10.1002/jmv.26490.
    >> Share

    August 2020
  15. KUMAR R, Chan KP, Ekstrom VSM, Wong JCC, et al
    Hepatitis C Virus antigen detection is an appropriate test for screening and early diagnosis of hepatitis C virus infection in at-risk populations and immunocompromised hosts.
    J Med Virol. 2020 Aug 14. doi: 10.1002/jmv.26433.
    >> Share

  16. RIDRUEJO E, Pinero F, Mendizabal M, Cheinquer H, et al
    Decompensated cirrhosis and liver transplantation negatively impact in DAA treatment response: Real-world experience from HCV-LALREAN cohort.
    J Med Virol. 2020 Aug 4. doi: 10.1002/jmv.26383.
    >> Share

    July 2020
  17. FAROOQ M, Rauf M, Tahir F, Manzoor S, et al
    "A comparative analysis of interferons and direct-acting antivirals on the expression of genes involved in hepatitis C pathogenesis".
    J Med Virol. 2020 Jul 24. doi: 10.1002/jmv.26351.
    >> Share

    June 2020
  18. HAN W, Li J, Zhou H, Qian J, et al
    Identification of the association of CD28(+) CD244(+) Tc17/IFN-gamma cells with chronic hepatitis C virus infection.
    J Med Virol. 2020 Jun 22. doi: 10.1002/jmv.26205.
    >> Share

  19. ABO EL-KHAIR SM, El-Alfy HA, Elsamanoudy AZ, Elhammady D, et al
    Development of a novel glycated protein-based fibrosis prediction score for determination of significant liver fibrosis in HCV-infected patients, a preliminary study.
    J Med Virol. 2020 Jun 19. doi: 10.1002/jmv.26204.
    >> Share

  20. XIAO L, Wu X, Zhang F, Wang J, et al
    Changes of inflammatory cytokines/chemokines during ravidasvir plus ritonavir-boosted danoprevir and ribavirin therapy for patients with genotype 1 b hepatitis C infection.
    J Med Virol. 2020 Jun 11. doi: 10.1002/jmv.26161.
    >> Share

  21. SEBASTIAO CS, Neto Z, Jandondo D, Mirandela M, et al
    HIV, hepatitis B virus, hepatitis C virus, and syphilis among pregnant women attending antenatal care in Luanda, Angola: seroprevalence and risk factors.
    J Med Virol. 2020 Jun 9. doi: 10.1002/jmv.26148.
    >> Share

    May 2020
  22. MOHAMADI M, Azarbayjani K, Mozhgani SH, Bamdad T, et al
    Hepatitis C virus alternative reading frame protein (ARFP): production, features and pathogenesis.
    J Med Virol. 2020 May 29. doi: 10.1002/jmv.26091.
    >> Share

  23. WAHID B, Shami K, Joiya SA, Ozuyar SEG, et al
    Comparing the risk of hypothyroidism in HCV patients treated with different DAA drugs combinations (sofosbuvir + interferon + ribavirin and sofosbuvir + daclatasvir + ribavirin).
    J Med Virol. 2020 May 17. doi: 10.1002/jmv.25931.
    >> Share

  24. WATANABE T, Tokumoto Y, Joko K, Michitaka K, et al
    Sex difference in the development of hepatocellular carcinoma after direct-acting antiviral therapy in patients with HCV infection.
    J Med Virol. 2020 May 6. doi: 10.1002/jmv.25984.
    >> Share

    April 2020
  25. JAMIL Z, Waheed Y, Ahsan O, Najmi MH, et al
    Familial Clustering of Hepatitis C Virus in Pakistani Population.
    J Med Virol. 2020 Apr 22. doi: 10.1002/jmv.25926.
    >> Share

    March 2020
  26. JAMSHIDI S, Bokharaei-Salim F, Esghaei M, Bastani MN, et al
    Occult HCV and Occult HBV Co-infection in Iranian Human Immunodeficiency Virus-Infected Individuals.
    J Med Virol. 2020 Mar 31. doi: 10.1002/jmv.25808.
    >> Share

  27. MARGUSINO-FRAMINAN L, Perez EB, Cid-Silva P, Rodriguez-Sotelo A, et al
    Effectiveness and Safety of Direct-Acting Antivirals in Hepatitis C Infected Patients with Mental Disorders: Results in Real Clinical Practice.
    J Med Virol. 2020 Mar 17. doi: 10.1002/jmv.25772.
    >> Share

  28. MUSHTAQ S, Mansoor A, Umar M, Khan A, et al
    Direct-acting antiviral agents in the treatment of chronic Hepatitis C - Real-life experience from clinical practices in Pakistan.
    J Med Virol. 2020 Mar 4. doi: 10.1002/jmv.25745.
    >> Share

    February 2020
  29. LU C, Feng Y, Sun X, Li N, et al
    Tree Shrew Bone Marrow-Derived Mesenchymal Stem Cells Express CD81, OCLN, and miR-122, Facilitating the Entire Hepatitis C Virus Life Cycle.
    J Med Virol. 2020 Feb 13. doi: 10.1002/jmv.25710.
    >> Share

    December 2019
  30. FUCHS M, Monto A, Brau N, Charafeddine M, et al
    Ombitasvir/Paritaprevir/Ritonavir and Dasabuvir +/- Ribavirin for Chronic HCV Infection in US Veterans with Psychiatric Disorders.
    J Med Virol. 2019 Dec 12. doi: 10.1002/jmv.25655.
    >> Share

  31. KIM M, Kyung Lee Y, Park B, Jun Oh D, et al
    Hepatitis virus B and C infections are associated with an increased risk of non-Hodgkin lymphoma: A nested case-control study using a national sample cohort.
    J Med Virol. 2019 Dec 11. doi: 10.1002/jmv.25653.
    >> Share

    November 2019
  32. OMRAN NM, El-Sherbini SM, Hegazy O, Elshaarawy AA, et al
    Crosstalk between miR-215 and Epithelial-Mesenchymal Transition (EMT) specific markers (E- and N-cadherin) in different stages of chronic HCV Infection.
    J Med Virol. 2019 Nov 26. doi: 10.1002/jmv.25637.
    >> Share

  33. DEL-RIOS NHA, de Araujo LA, Martins RMB, Guimaraes RA, et al
    Molecular and Epidemiological Aspects of Hepatitis C Virus Infection Among Crack Cocaine Users.
    J Med Virol. 2019 Nov 20. doi: 10.1002/jmv.25632.
    >> Share

    October 2019
  34. GRABARCZYK P, Kubicka-Russel D, Kopacz A, Liszewski G, et al
    Seronegative hepatitis C virus (HCV) infection in Polish blood donors - virological characteristics of index donations and follow-up observations.
    J Med Virol. 2019 Oct 31. doi: 10.1002/jmv.25617.
    >> Share

  35. MAHMUD S, Chemaitelly HS, Kouyoumjian SP, Kanaani ZA, et al
    Key associations for hepatitis C virus genotypes in the Middle East and North Africa.
    J Med Virol. 2019 Oct 30. doi: 10.1002/jmv.25614.
    >> Share

  36. TSAI TC, Deng ST, Hsu CW
    The efficacy and safety of elbasvir/grazoprevir treatment in HCV genotype 1 patients in Taiwan.
    J Med Virol. 2019 Oct 10. doi: 10.1002/jmv.25605.
    >> Share

  37. SAITO Y, Imamura M, Uchida T, Osawa M, et al
    Ribavirin induces hepatitis C virus genome mutations in chronic hepatitis patients who failed to respond to prior daclatasvir plus asunaprevir therapy.
    J Med Virol. 2019 Oct 4. doi: 10.1002/jmv.25602.
    >> Share

    January 2019
  38. KWEON OJ, Lim YK, Kim HR, Kim TH, et al
    Analytical Performance of Newly Developed Rapid Point-of-Care Test for the Simultaneous Detection of Hepatitis A, B, and C Viruses in Serum Samples.
    J Med Virol. 2019 Jan 22. doi: 10.1002/jmv.25405.
    >> Share

    October 2018
  39. YANG H, Wu J, Yuan Y, Huang W, et al
    Retrospectively Seroprevalence Study on Anti-HEV-IgG antibody in patients with chronic hepatitis or liver cirrhosis in a Chinese teaching hospital.
    J Med Virol. 2018 Oct 11. doi: 10.1002/jmv.25335.
    >> Share


Free Medical Abstracts
Privacy Policy
Sponsors
Share

© Amedeo 1997-2016